These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19949353)

  • 1. Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?
    Vyas NS; Patel NH; Nijran KS; Al-Nahhas A; Puri BK
    Nucl Med Commun; 2010 Feb; 31(2):91-3. PubMed ID: 19949353
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography in schizophrenia: a new perspective.
    Patel NH; Vyas NS; Puri BK; Nijran KS; Al-Nahhas A
    J Nucl Med; 2010 Apr; 51(4):511-20. PubMed ID: 20237027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia research. Neurobiology/imaging.
    J Psychiatry Neurosci; 1994 Nov; 19(5 Suppl 1):39-42. PubMed ID: 7803380
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural and functional brain imaging in schizophrenia.
    Cleghorn JM; Zipursky RB; List SJ
    J Psychiatry Neurosci; 1991 Jul; 16(2):53-74. PubMed ID: 1911736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression in schizophrenia: II. MRI and PET findings.
    Kohler C; Swanson CL; Gur RC; Mozley LH; Gur RE
    Biol Psychiatry; 1998 Feb; 43(3):173-80. PubMed ID: 9494698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain imaging in schizophrenia -- especially by Computed Tomography].
    Szulc A
    Psychiatr Pol; 1994; 28(2):145-56. PubMed ID: 8208861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroimaging in schizophrenia].
    Lanzenberger R; Kasper S
    Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S51-9. PubMed ID: 16270245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET scanning in schizophrenia, a critical evaluation. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Murphy D; Rapoport SI
    Neuropsychopharmacology; 1992 Aug; 7(1):59-61; discussion 73-5. PubMed ID: 1524656
    [No Abstract]   [Full Text] [Related]  

  • 10. Confounds in CT studies of schizophrenia.
    Br J Psychiatry; 1990 Mar; 156():444-5. PubMed ID: 2346855
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroimaging in schizophrenia: misattributions and religious delusions.
    Taber KH; Hurley RA
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):iv-4. PubMed ID: 17308221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative studies of brain CT scan in schizophrenia].
    Zhai S
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Aug; 25(4):211-4, 253. PubMed ID: 1478136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography scans in schizophrenia.
    Pal H; Saxena S
    Natl Med J India; 1994; 7(2):74. PubMed ID: 8019402
    [No Abstract]   [Full Text] [Related]  

  • 15. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF
    Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular imaging of psychiatric disorders].
    Takahashi H; Suhara T
    Nihon Rinsho; 2007 Feb; 65(2):336-41. PubMed ID: 17302281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
    Frankle WG; Narendran R; Huang Y; Hwang DR; Lombardo I; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Jun; 57(12):1510-6. PubMed ID: 15953487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter.
    Arakawa R; Ichimiya T; Ito H; Takano A; Okumura M; Takahashi H; Takano H; Yasuno F; Kato M; Okubo Y; Suhara T
    J Psychiatr Res; 2009 Oct; 43(15):1219-23. PubMed ID: 19457493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
    Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.